Baicalin methyl ester

CAS No. 82475-03-4

Baicalin methyl ester ( —— )

Catalog No. M21819 CAS No. 82475-03-4

Baicalin methyl ester is a constituent of the roots of S. baicalmsis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 124 In Stock
10MG 178 In Stock
25MG 312 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Baicalin methyl ester
  • Note
    Research use only, not for human use.
  • Brief Description
    Baicalin methyl ester is a constituent of the roots of S. baicalmsis.
  • Description
    Baicalin methyl ester is a constituent of the roots of S. baicalmsis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    82475-03-4
  • Formula Weight
    460.39
  • Molecular Formula
    C??H??O??
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (543.02 mM)
  • SMILES
    OC1=C2C(OC(C3=CC=CC=C3)=CC2=O)=CC(O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(OC)=O)=C1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. KazutakaNishikawa, et al. Flavonoids in root cultures of Scutellaria baicalensis. Journal of Plant Physiology. 1997, 151(5): 633-636.
molnova catalog
related products
  • Bernardioside A

    Bernardioside A is a natural product.

  • Xanthoangelol

    Xanthoangelol, which can be extracted from Angelica keiskei, inhibits obesity-induced inflammatory responses.Xanthoangelol has antimicrobial activity, inhibits monoamine oxidase, and induces apoptosis in neuroblastoma and leukemia cells.

  • Trastuzumab deruxtec...

    Trastuzumab deruxtecan (T-DXd) is an antibody-active molecule conjugate (ADC) with anticancer and antitumor activity, which is composed of a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2) coupled to a topoisomerase I inhibitor (DXd).